Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec 1;1(4):10.1007/s40142-013-0025-3.
doi: 10.1007/s40142-013-0025-3.

Pathway analyses and understanding disease associations

Yu Liu  1 , Mark R Chance
Affiliations

Pathway analyses and understanding disease associations

Yu Liu et al. Curr Genet Med Rep. .

Abstract

High throughput technologies have been applied to investigate the underlying mechanisms of complex diseases, identify disease-associations and help to improve treatment. However it is challenging to derive biological insight from conventional single gene based analysis of "omics" data from high throughput experiments due to sample and patient heterogeneity. To address these challenges, many novel pathway and network based approaches were developed to integrate various "omics" data, such as gene expression, copy number alteration, Genome Wide Association Studies, and interaction data. This review will cover recent methodological developments in pathway analysis for the detection of dysregulated interactions and disease-associated subnetworks, prioritization of candidate disease genes, and disease classifications. For each application, we will also discuss the associated challenges and potential future directions.

Keywords: Genome Wide Association Studies (GWAS); Pathway analysis; disease association; disease classification; dysregulated interaction; gene prioritization.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of pathway analysis and understanding disease associations. Pathway analysis can be used to detect dysregulated interactions and disease-associated pathways, prioritize candidate disease genes, and classify diseases.
See this image and copyright information in PMC

References

    1. Ashley EA, Butte AJ, Wheeler MT, et al. Clinical assessment incorporating a personal genome. Lancet. 2010;375(9725):1525–1535. - PMC - PubMed
    1. Chen R, Mias GI, Li-Pook-Than J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148(6):1293–1307. - PMC - PubMed
    1. Lander ES. Initial impact of the sequencing of the human genome. Nature. 2011;470(7333):187–197. - PubMed
    1. Friend SH, Ideker T. POINT: Are We Prepared For the Future Doctor Visit? Nat Biotechnol. 2011;29(3):215–218. - PubMed

    1. Vidal M, Cusick ME, Barabasi AL. Interactome networks and human disease. Cell. 2011;144(6):986–998. This article presnts an excellent review about how networks can be used to study human diseases.

LinkOut - more resources